BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sings HL, Gessner BD, Wasserman MD, Jodar L. Pneumococcal Conjugate Vaccine Impact on Serotype 3: A Review of Surveillance Data. Infect Dis Ther 2021;10:521-39. [PMID: 33587245 DOI: 10.1007/s40121-021-00406-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Liatsikos K, Hyder-Wright A, Pojar S, Chen T, Wang D, Davies K, Myerscough C, Reine J, Robinson RE, Urban B, Mitsi E, Solorzano C, Gordon SB, Quinn A, Pan K, Anderson AS, Theilacker C, Begier E, Gessner BD, Collins A, Ferreira DM; PNEUMO 2 study group. Protocol for a phase IV double-blind randomised controlled trial to investigate the effect of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine on pneumococcal colonisation using the experimental human pneumococcal challenge model in healthy adults (PREVENTING PNEUMO 2). BMJ Open 2022;12:e062109. [PMID: 35798520 DOI: 10.1136/bmjopen-2022-062109] [Reference Citation Analysis]
2 Liapikou A, Konstantinidis A, Kossyvaki V, Skiadas J, Menegas D, Méndez C, Beavon R, Begier E, Gessner BD, Milionis H, Tsimihodimos V, Baxevanos G, Argiriadou T, Terrovitou C, Toumbis M, Study Group TE, Moses E, Angelos L, Ilias T, Aikaterini P, Valentina S, Iro R, Konstantinos E, Konstantina G, Christos K, Elias L, Thomas T, Georgios D, Evaggelia C, Nikolaos Z, Lampros P, Vasilios I, Elisavet F, Daniil D, Ioanna K, Anastasia C, Eleni T; EGNATIA Study Group. Pneumococcal serotypes in adults hospitalized with community-acquired pneumonia in Greece using urinary antigen detection tests: the EGNATIA study, November 2017 - April 2019. Hum Vaccin Immunother 2022;:2079923. [PMID: 35703733 DOI: 10.1080/21645515.2022.2079923] [Reference Citation Analysis]
3 Leblanc JJ, Elsherif M, Ye L, Mackinnon-cameron D, Ambrose A, Hatchette TF, Lang AL, Gillis HD, Martin I, Demczuk WH, Andrew MK, Boivin G, Bowie W, Green K, Johnstone J, Loeb M, Mccarthy AE, Mcgeer A, Semret M, Trottier S, Valiquette L, Webster D, Mcneil SA. Recalibrated estimates of non-bacteremic and bacteremic pneumococcal community acquired pneumonia in hospitalized Canadian adults from 2010 to 2017 with addition of an extended spectrum serotype-specific urine antigen detection assay. Vaccine 2022. [DOI: 10.1016/j.vaccine.2022.02.081] [Reference Citation Analysis]
4 Theilacker C, Fletcher MA, Jodar L, Gessner BD. PCV13 Vaccination of Adults against Pneumococcal Disease: What We Have Learned from the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA). Microorganisms 2022;10:127. [PMID: 35056576 DOI: 10.3390/microorganisms10010127] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
5 Vyse A, Campling J, Czudek C, Ellsbury G, Mendes D, Reinert RR, Slack M. A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK. Expert Rev Vaccines 2021;20:1311-25. [PMID: 34550850 DOI: 10.1080/14760584.2021.1984888] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Silva-Costa C, Gomes-Silva J, Prados L, Ramirez M, Melo-Cristino J, On Behalf Of The Portuguese Group For The Study Of Streptococcal Infections, The Portuguese Study Group Of Invasive Pneumococcal Disease Of The Pediatric Infectious Disease Society. Pediatric Invasive Pneumococcal Disease Three Years after PCV13 Introduction in the National Immunization Plan-The Continued Importance of Serotype 3. Microorganisms 2021;9:1428. [PMID: 34361864 DOI: 10.3390/microorganisms9071428] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Gessner BD, Isturiz R, Snow V, Grant LR, Theilacker C, Jodar L. The rationale for use of clinically defined outcomes in assessing the impact of pneumococcal conjugate vaccines against pneumonia. Expert Rev Vaccines 2021;20:269-80. [PMID: 33602035 DOI: 10.1080/14760584.2021.1889376] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]